Global buyout giant Blackstone has agreed to acquire Australian clinical trials provider Nucleus Network.
The post Blackstone to acquire Australian clinical trials provider Nucleus Network eyeing increasing demand from offshore biotech companies first appeared on AltAssets Private Equity News.
